Level Biotechnology (3118) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, Level Biotechnology (3118) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$11.81 Million ≈ $372.24K USD) by net assets (NT$562.82 Million ≈ $17.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Level Biotechnology market cap and net worth for the company's overall valuation and market capitalisation.

Level Biotechnology - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Level Biotechnology's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Level Biotechnology Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Level Biotechnology ranked by their cash flow conversion efficiency. Explore cash flow quality index of Level Biotechnology to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
The Australian Wealth Advisors Group Ltd AU:WAG	0.033x
Asia Brands Bhd KLSE:7722	0.015x
Chiu Ting Machinery Co Ltd TW:1539	0.044x
Avertronics TWO:3597	-0.066x
Terramin Australia Ltd AU:TZN	-0.346x
NATUZZI S.P.A. ADR/5 EO 1 F:NTZA	-0.043x
North Energy ASA OL:NORTH	-0.014x
BOS Better Online Solutions NASDAQ:BOSC	0.176x

Annual Cash Flow Conversion Efficiency for Level Biotechnology (2017–2024)

The table below shows the annual cash flow conversion efficiency of Level Biotechnology from 2017 to 2024. View 3118 live share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	NT$559.91 Million ≈ $17.64 Million	NT$64.10 Million ≈ $2.02 Million	0.114x	-10.41%
2023-12-31	NT$549.47 Million ≈ $17.31 Million	NT$70.21 Million ≈ $2.21 Million	0.128x	+6.51%
2022-12-31	NT$542.40 Million ≈ $17.09 Million	NT$65.07 Million ≈ $2.05 Million	0.120x	-58.09%
2021-12-31	NT$544.84 Million ≈ $17.17 Million	NT$155.95 Million ≈ $4.91 Million	0.286x	+82.08%
2020-12-31	NT$529.43 Million ≈ $16.68 Million	NT$83.23 Million ≈ $2.62 Million	0.157x	-25.92%
2019-12-31	NT$513.75 Million ≈ $16.19 Million	NT$109.02 Million ≈ $3.43 Million	0.212x	+295.34%
2018-12-31	NT$498.78 Million ≈ $15.71 Million	NT$26.77 Million ≈ $843.50K	0.054x	-60.68%
2017-12-31	NT$522.28 Million ≈ $16.45 Million	NT$71.29 Million ≈ $2.25 Million	0.136x	--

About Level Biotechnology

TWO:3118 Taiwan Biotechnology

Market Cap

$32.10 Million

NT$1.02 Billion TWD

Market Cap Rank

#23604 Global

#1470 in Taiwan

Share Price

NT$31.40

Change (1 day)

-0.79%

52-Week Range

NT$30.95 - NT$34.10

All Time High

NT$37.15